EN
РусскийEnglishEspañol — próximamenteFrançais — bientôtDeutsch — in VorbereitungItaliano — in arrivoAll languages

A coagulation panel in plain words: INR, APTT, fibrinogen, and D-dimer

Why clotting is tested before surgery and during blood-thinner therapy, and what each line of the panel actually measures.

In shortA coagulation panel is a set of tests about how blood clots. INR reflects the extrinsic clotting pathway and steers warfarin dosing (typical range without anticoagulants: 0.8–1.1), APTT times the intrinsic pathway (usually 25–35 seconds), fibrinogen is the raw material of a clot (2.0–4.0 g/L), and D-dimer is the debris of a dissolved one. The panel matters before surgery, with unexplained bruising, after clots, and during anticoagulant therapy.

Why clotting is measured at all

The clotting system balances between two dangers: bleeding when a clot fails to form, and thrombosis when one forms where it should not. Each line of the panel looks at a different link in this chain, and the numbers only make sense together.

Panels are ordered before operations and deliveries, for unexplained bruising or bleeding, after a thrombosis, and to dose anticoagulants. Testing clotting without a clinical question rarely helps: isolated numbers without context mean very little.

INR and APTT: the two headline numbers

INR is prothrombin time recalculated to an international scale. People not taking anticoagulants usually sit between 0.8 and 1.1, while those on warfarin are kept inside a target range, often 2.0–3.0. Everyone on warfarin has INR checked on a schedule.

APTT times the intrinsic pathway in seconds, with a typical range of 25–35. It helps investigate haemophilia and von Willebrand disease and monitors unfractionated heparin. A prolonged APTT without medication points toward clotting factor problems.

Fibrinogen and D-dimer: the material and the trace

Fibrinogen is the protein a clot is built from, typically 2.0–4.0 g/L (200–400 mg/dL). It rises with inflammation, after surgery, and in pregnancy, so a moderate increase is a common finding, while a sharp drop accompanies serious clotting disorders.

D-dimer is a fragment of broken-down fibrin. Its main power is a negative result: a normal level with low clinical probability lets the doctor rule out thrombosis without imaging. A raised D-dimer is nonspecific — it climbs with inflammation, after operations, in pregnancy, and with age.

How to take and read the panel

Blood is drawn into a citrate tube that must be filled to the mark — an underfilled tube distorts results. Tell the laboratory about every medication: anticoagulants change INR and APTT by design, and the result is read against that intention.

Never read the panel line by line. A prolonged APTT with a normal INR points toward intrinsic-pathway factors; both rising together suggests liver trouble or vitamin K deficiency. The final interpretation belongs to a clinician who knows the history.

Who needs a coagulation panel most

  • Anyone facing surgery or delivery — as ordered by the surgeon
  • People on warfarin — scheduled INR monitoring
  • Unexplained bruising, bleeding gums, or frequent nosebleeds
  • A personal or family history of thrombosis
  • Suspected thrombosis — D-dimer as the first ruling-out step

Markers covered in this article

Several markers on your report?

See how MedProtect explains results in the app: the whole report, a check of the recognized values, and a clear breakdown.

Frequently asked questions

Is a coagulation panel one test or several?
Several. The minimum is INR (prothrombin time), APTT, and fibrinogen; D-dimer, platelets, and antithrombin are often added. The exact set depends on the question — preoperative screening and warfarin control use different combinations.
Can the panel tell whether blood is "too thick"?
Loosely, yes, though doctors avoid that phrasing. A clotting tendency shows as a pattern: short APTT, high fibrinogen, raised D-dimer plus clinical signs. A single number proves nothing.
Is fasting required?
Most laboratories prefer a morning fasting draw to reduce plasma interference. What matters more is not changing anticoagulant doses on your own and declaring them to the laboratory.

Sources

  1. Prothrombin time (PT): MedlinePlus Medical Encyclopedia — MedlinePlus, National Library of Medicine. Accessed: August 31, 2026.
  2. Partial thromboplastin time (PTT): MedlinePlus Medical Encyclopedia — MedlinePlus, National Library of Medicine. Accessed: August 31, 2026.
  3. Fibrinogen blood test: MedlinePlus Medical Encyclopedia — MedlinePlus, National Library of Medicine. Accessed: August 31, 2026.
  4. D-Dimer Test: MedlinePlus Medical Test — MedlinePlus, National Library of Medicine. Accessed: August 31, 2026.

Keep reading